Cotinga Pharmaceuticals Deuda/Patrimonio neto
¿Qué es el Deuda/Patrimonio neto de Cotinga Pharmaceuticals?
El Deuda/Patrimonio neto de Cotinga Pharmaceuticals, Inc. es -1.52
¿Cuál es la definición de Deuda/Patrimonio neto?
La relación deuda / patrimonio neto es una relación financiera que indica la proporción relativa del capital contable y la deuda utilizada para financiar los activos de una empresa.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Deuda/Patrimonio neto de compañías en Sector Health Care en TSXV en comparadas con Cotinga Pharmaceuticals
¿Qué hace Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Empresas con deuda/patrimonio neto similar a Cotinga Pharmaceuticals
- The State Trading of India tiene Deuda/Patrimonio neto de -1.54
- Aquestive Therapeutics Inc tiene Deuda/Patrimonio neto de -1.54
- Routemaster Capital tiene Deuda/Patrimonio neto de -1.54
- NeutriSci International tiene Deuda/Patrimonio neto de -1.54
- Citrine Global, Corp tiene Deuda/Patrimonio neto de -1.53
- DomaCom tiene Deuda/Patrimonio neto de -1.53
- Cotinga Pharmaceuticals tiene Deuda/Patrimonio neto de -1.52
- Alpha Cognition tiene Deuda/Patrimonio neto de -1.52
- Sequana Medical NV tiene Deuda/Patrimonio neto de -1.52
- Greenbrook TMS tiene Deuda/Patrimonio neto de -1.51
- Resources of Australia Ltd tiene Deuda/Patrimonio neto de -1.51
- Mobio Technologies tiene Deuda/Patrimonio neto de -1.51
- PowerBand Solutions tiene Deuda/Patrimonio neto de -1.51